FactSet Research Systems (FDS)

Servicios financieros / Datos y analítica

FactSet provides data, analytics and technology to investment professionals with subscription retention above 95% and a unique regulatory franchise in securities identifiers (CUSIP), but faces well-funded competitors with artificial-intelligence capabilities and a structural headwind toward passive management; the cash generated funds a very active share buyback that sustains total return even at a moderate multiple.

Moat Compounder estimates the intrinsic value of FactSet Research Systems (FDS) at $572 per share on a five-year horizon. With the stock at $301.96 at 2026-09-04 close, the expected total return is 15.1% per year: very undervalued. The analysis draws on 10-K FY2025 and 8-K Q3 FY2026 earnings. Analysis dated 2026-07-01.

Price
$301.96
at 2026-09-04 close
Intrinsic value (5y, base)
$572
Total annual return (5y)
15.1%
13.6% price · 1.4% div
Status (nominal)
Very undervalued
Margin of safety
+38%

The essentials

  • ASV retention above 95% and client retention of 91% (FY2025), reflecting high switching costs in mission-critical investment workflows.
  • CUSIP Global Services is the exclusive global issuer of CUSIP and CINS identifiers and ISIN numbering agency in more than 30 countries — a regulatory franchise with no direct comparison among the named competitors.
  • Organic growth holds in the high single digits (organic ASV +7.1% year over year as of May 2026), but the GAAP operating margin compressed on non-recurring CEO-transition, restructuring and impairment charges.
  • Very active share buyback (US$612.6 million over the trailing twelve months, ~5.6% of market value), with the diluted share count falling from 38.4 to 36.2 million in one year.
Source 10-K FY2025 2025-10-22 ·8-K Q3 FY2026 earnings 2026-07-01 ·DEF 14A 2025 (proxy) 2025-10-27
Health: Solid
Price $302 at 2026-09-04 closeMarket Cap $10.9 bnEnterprise Value $12 bnNet debt $1.1 bnP/E (today) 19.3x

Intrinsic value — two valuation methods

Fairly valued
Price market
$302
DCF value today
$449
+48.7% vs price
Multiples value today
$483
+60.0% vs price

Total return at 5 years: 15.1%/year = 13.6% appreciation + 1.4% dividend. The target price ($572) is ex-dividend; the $28 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $449 · Multiples $483) exceeds the market price ($302).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $302 trades ~37.5% below its value discounted to today (~$483); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — Muy infravalorado: the target price ($572) plus dividends yield above the required average return (10%) — the business compounds.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$303.

Thesis

The business

Financial data and analytics provider with subscription retention above 95%, capital-light (TTM capex is below depreciation and amortization), and real return on invested capital of ~19.1% — in the excellent category against the 10% bar. The moat is switching costs plus a narrow regulatory position in CUSIP, not as wide as that of an index provider, and its direction reads as stable against intensifying competition.

The valuation

Valued on P/E over comparable net income, with an exit multiple of 19× in the base case — in the lower third of the financial data archetype band [20-26x], reflecting a narrower moat than an index or credit-rating provider. This yields a 5-year value of $572 per share, a +15% annual return at the market price.

The margin of safety

There is a margin of safety: the market's perception is meaningfully worse than reality. The market price (US$$302) is compared against a value today derived from the flow discounted at the risk-free rate with floor. The very active share buyback (~5.6% of market value over the trailing twelve months) contributes to total return by reducing the projected share count, without requiring a multiple re-rating.

What to watch

The central disconfirmer is whether the margin compression in the third quarter of fiscal 2026 (CEO-transition, restructuring and impairment charges) is transitory, as the reaffirmed full-year guidance suggests, or marks the start of more structural cost pressure from intensifying competition from rivals with artificial-intelligence capabilities. If organic ASV growth falls below the guided range (US$130-160 million), the base case loses its primary anchor.

Educational / informational. Does not constitute investment advice.

Other companies of the same type